8th March 2013 by Louise Hudman
This guidance is another new drug for the use in AF as an anticoagulant. It is a Factor Xa inhibitor and is more effective than warfarin. It hasn’t been shown to be more effective than Rivaroxaban and Dabigatran. It has the lowest bleeding risk. As always, we should wait for local prescribing advice before using.
It can be considered if the patient has non-valvular AF and at least 1 of:
"I love getting an email to say 'a new GP locum has linked with your practice', especially when the offer of sessions is just what I’d been needing and it’s just dropped into my lap! It’s great to have everything in one place and be able to download documents so easily. LocumDeck makes the terms and conditions of each locum really clear, and I’ve built up a really good amount of offers from different GPs. It’s easy to keep track of invoices and pension forms, and it’s great that it’s free for practices to use too."
Jennie Dock, Practice Manager, Hedge End Medical Centre, Southampton, Hampshire